Outcomes of anti-viral therapy in herpes simplex keratitis

被引：0
|
作者：
Cabrera-Aguas, Maria [1 ,2 ]
Robaei, Dana [1 ,3 ]
Watson, Stephanie L. [1 ,2 ]
机构：
[1] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
[2] Sydney Eye Hosp, Sydney, NSW, Australia
[3] Westmead Hosp, Westmead, NSW, Australia
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3650
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ANTI-VIRAL DRUGS FOR HERPES-SIMPLEX KERATITIS
    SOLL, DB
    OBROTKA, TM
    AMERICAN FAMILY PHYSICIAN, 1977, 16 (06) : 116 - 117
  • [2] ANTI-VIRAL DROPS - COMPARATIVE THERAPY OF EXPERIMENTAL HERPES-SIMPLEX KERATOUVEITIS
    PAVANLANGSTON, D
    LASS, J
    CAMPBELL, R
    ARCHIVES OF OPHTHALMOLOGY, 1979, 97 (06) : 1132 - 1135
  • [3] THE ANTI-VIRAL EFFECT OF TUNICAMYCIN ON HERPES-SIMPLEX VIRUS
    KATZ, E
    MARGALITH, E
    DUKSIN, D
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1980, 16 (06): : 484 - 485
  • [4] ANTI-VIRAL TREATMENT OF VARICELLA ZOSTER AND HERPES-SIMPLEX
    不详
    LANCET, 1980, 1 (8182): : 1337 - 1339
  • [5] ANTI-VIRAL ACTIVITY OF TUNICAMYCIN ON HERPES-SIMPLEX VIRUS
    KATZ, E
    MARGALITH, E
    DUKSIN, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) : 1014 - 1022
  • [6] RECURRENT HERPES-SIMPLEX AND SYSTEMIC ANTI-VIRAL AGENTS
    MAYNE, DG
    BRITISH MEDICAL JOURNAL, 1981, 282 (6282): : 2139 - 2139
  • [7] RECURRENT HERPES-SIMPLEX - THE OUTLOOK FOR SYSTEMIC ANTI-VIRAL AGENTS
    FIELD, HJ
    WILDY, P
    BMJ-BRITISH MEDICAL JOURNAL, 1981, 282 (6279): : 1821 - 1822
  • [8] INHIBITION OF HERPES-SIMPLEX VIRUS MULTIPLICATION BY THE POKEWEED ANTI-VIRAL PROTEIN
    ARON, GM
    IRVIN, JD
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (06) : 1032 - 1033
  • [9] The latest in herpes simplex keratitis therapy
    Labetoulle, M
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2004, 27 (05): : 547 - 557
  • [10] THERAPY OF EXPERIMENTAL HERPES SIMPLEX KERATITIS
    KAUFMAN, HE
    HOWARD, GM
    INVESTIGATIVE OPHTHALMOLOGY, 1962, 1 (04): : 561 - 564
12345